Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study

We analyzed the treatment responses, toxicities, and survival outcomes of patients with relapsed or refractory multiple myeloma who received daily thalidomide, cyclophosphamide, and dexamethasone (CTD) or daily thalidomide, melphalan, and prednisolone (MTP) at 17 medical centers in Korea. Three‐hund...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Kwon, Jihyun, Min, Chang‐Ki, Kim, Kihyun, Han, Jae‐joon, Moon, Joon Ho, Kang, Hye Jin, Eom, Hyeon‐Seok, Kim, Min Kyoung, Kim, Hyo Jung, Yoon, Dok Hyun, Lee, Jeong‐Ok, Lee, Won Sik, Lee, Jae Hoon, Lee, Je‐Jung, Choi, Yoon‐seok, Kim, Sung hyun, Yoon, Sung‐soo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5269709/
https://ncbi.nlm.nih.gov/pubmed/27905203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.970
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados